Although erlotinib treatment did not inhibit basal growth of PC-10 cells in vitro (Fig. 4c), it did suppress the growth of PC-10 tumour xenografts in vivo and EGFR phosphorylation in the tumour (Fig. 5a and b). This evidence concerns the gene EGFR and neoplasm.